Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.25 USD | +1.67% | +1.72% | +5.36% |
12:00am | Aegon Ltd. Appoints Chief Strategy, Transformation and Growth Officer and Member of Executive Committee, Effective November 1, 2024 | CI |
09-13 | Zenas BioPharma Shares Rise in Nasdaq Debut | MT |
Composite Fundamentals | Composite Valuation | Composite Consensus | Composite Momentum | Composite Visibility | Investor Rating | ESG Refinitiv | Capi. ($) | ||
---|---|---|---|---|---|---|---|---|---|
C- | 159B | ||||||||
C+ | 160B | ||||||||
B- | 114B | ||||||||
C+ | 110B | ||||||||
B+ | 36.51B | ||||||||
B | 24.28B | ||||||||
B+ | 18.58B | ||||||||
C- | 16.64B | ||||||||
B | 16.06B | ||||||||
B+ | 15.38B | ||||||||
A- | 14.85B | ||||||||
C+ | 13.88B | ||||||||
B+ | 13.78B | ||||||||
A | 12.25B | ||||||||
C+ | 12.03B | ||||||||
B | 11.72B | ||||||||
A- | 10.16B | ||||||||
B- | 9.16B | ||||||||
C | 8.79B | ||||||||
- | C | 7.95B | |||||||
Average | B- | 39.21B | |||||||
Weighted average by Cap. | B- |
- Stock Market
- Equities
- MS Stock
- Sector Morgan Stanley
- Sector ratings
MarketScreener is also available in this country: United States.
Switch edition